• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

艾滋病如何以及为何改变了瑞士的毒品政策。

How and why AIDS changed drug policy in Switzerland.

出版信息

J Public Health Policy. 2012 Aug;33(3):317-24. doi: 10.1057/jphp.2012.20.

DOI:10.1057/jphp.2012.20
PMID:22895501
Abstract

Switzerland implemented a harm reduction program and reduced the spread of HIV within the drug scene, and from drug users into other population groups, earlier than many countries. Each canton developed strategies based on its drug problem. By 1985 it was obvious that 'needle sharing' was the most significant pathway in the transmission of HIV. Some cities established Drug Consumption Rooms and small-scale syringe exchange programs. However, a dramatic concentration of drug use in the Platzspitz (a park) of Zürich evolved where 1000-2000 drug users gathered daily, many of whom were infected with HIV. The Federal Office of Public Health financed needle exchange and other harm reduction programs, with evaluation. Within a few years the Swiss established low-threshold methadone treatment programs and Heroin-Assisted Therapy. In 2008, the Swiss approved a law based on the principles of a 'four pillar system': repression, prevention, harm reduction, and treatment.

摘要

瑞士较早实施了减少伤害计划,在毒品场所内和在吸毒者之间减少了艾滋病毒的传播,并传播到其他人群中。每个州都根据其毒品问题制定了战略。到 1985 年,“共用针头”显然是 HIV 传播的最重要途径。一些城市建立了吸毒者娱乐室和小规模的注射器交换计划。然而,在苏黎世的普拉茨斯皮茨(一个公园)出现了毒品使用急剧集中的情况,每天有 1000-2000 名吸毒者聚集在这里,其中许多人感染了 HIV。联邦公共卫生办公室为针头交换和其他减少伤害计划提供资金,并进行评估。在短短几年内,瑞士建立了低门槛美沙酮治疗计划和海洛因辅助治疗。2008 年,瑞士根据“四大支柱系统”的原则批准了一项法律:镇压、预防、减少伤害和治疗。

相似文献

1
How and why AIDS changed drug policy in Switzerland.艾滋病如何以及为何改变了瑞士的毒品政策。
J Public Health Policy. 2012 Aug;33(3):317-24. doi: 10.1057/jphp.2012.20.
2
Failed drug policies in the United States and the future of AIDS: a perfect storm.美国失败的毒品政策与艾滋病的未来:完美风暴。
J Public Health Policy. 2012 Aug;33(3):309-16. doi: 10.1057/jphp.2012.16.
3
Heroin-assisted treatment in Switzerland: a case study in policy change.瑞士的海洛因辅助治疗:政策变革案例研究。
Addiction. 2010 Jan;105(1):29-37. doi: 10.1111/j.1360-0443.2009.02741.x. Epub 2009 Nov 17.
4
Switzerland, HIV and the power of pragmatism: lessons for drug policy development.瑞士、艾滋病病毒与实用主义的力量:对毒品政策制定的启示。
Int J Drug Policy. 2012 Jan;23(1):82-6. doi: 10.1016/j.drugpo.2011.07.011. Epub 2011 Aug 17.
5
The early response to AIDS in Switzerland: a personal view.瑞士对艾滋病的早期反应:个人观点。
J Public Health Policy. 2012 Aug;33(3):301-8. doi: 10.1057/jphp.2012.19.
6
Drug use and HIV/AIDS in China.中国的药物使用与艾滋病毒/艾滋病
Drug Alcohol Rev. 2006 Mar;25(2):173-5. doi: 10.1080/09595230500538835.
7
Malaysia and harm reduction: the challenges and responses.马来西亚与减少伤害:挑战与应对措施
Int J Drug Policy. 2007 Mar;18(2):136-40. doi: 10.1016/j.drugpo.2006.12.015. Epub 2007 Jan 29.
8
The transition to harm reduction: understanding the role of non-governmental organisations in Malaysia.向减少伤害转变:了解马来西亚非政府组织的作用。
Int J Drug Policy. 2011 Jul;22(4):311-7. doi: 10.1016/j.drugpo.2011.01.002. Epub 2011 Feb 5.
9
'Social evils' and harm reduction: the evolving policy environment for human immunodeficiency virus prevention among injection drug users in China and Vietnam.“社会弊病”与危害降低:中国和越南针对注射吸毒者预防人类免疫缺陷病毒的不断演变的政策环境
Addiction. 2008 Jan;103(1):137-45. doi: 10.1111/j.1360-0443.2007.02053.x. Epub 2007 Nov 20.
10
Clean needles save lives. HIV and injecting drug use.清洁针头能挽救生命。艾滋病毒与注射吸毒。
AIDS Action. 1993 Jun-Aug(21):4-5.

引用本文的文献

1
Abuse of tropicamide eye drops: review of clinical data.滥用托吡卡胺滴眼液:临床数据回顾。
Braz J Psychiatry. 2022 Nov 5;44(5):522-531. doi: 10.47626/1516-4446-2021-2446. Epub 2022 Jun 21.
2
Towards an International Consensus on the Prevention, Treatment, and Management of High-Risk Substance Use and Overdose among Youth.关于预防、治疗和管理青少年高危物质使用和药物过量的国际共识。
Medicina (Kaunas). 2022 Apr 13;58(4):539. doi: 10.3390/medicina58040539.
3
All-Cause Mortality and Causes of Death in the Swiss Hepatitis C Cohort Study (SCCS).
瑞士丙型肝炎队列研究(SCCS)中的全因死亡率和死亡原因
Open Forum Infect Dis. 2020 Jul 25;7(8):ofaa308. doi: 10.1093/ofid/ofaa308. eCollection 2020 Aug.
4
The Accessibility of Opioid Agonist Treatment and Its Forced Discontinuation in Swiss Prisons-Attitudes, Perceptions and Experiences of Defense Lawyers in Dealing With Detained Persons Using Opioids.瑞士监狱中阿片类激动剂治疗的可及性及其强制中断——辩护律师在处理使用阿片类药物的被拘留者时的态度、认知和经历
Front Psychiatry. 2020 May 14;11:395. doi: 10.3389/fpsyt.2020.00395. eCollection 2020.
5
Ethical dilemmas in protecting individual rights versus public protection in the case of infectious diseases.传染病情况下保护个人权利与公共保护之间的伦理困境。
Infect Dis (Auckl). 2013 Feb 28;6:1-5. doi: 10.4137/IDRT.S11205. eCollection 2013.